|
Jun 20
|
Navidea Biopharmaceuticals, Inc. announces special meeting of stockholders to be held July 8, 2024
|
|
Jan 27
|
Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations
|
|
Dec 1
|
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
|
|
May 22
|
Navidea Biopharmaceuticals, Inc. Investors Purchase $1.1 Million in Preferred Shares at Market
|